Offer - Urjas Oil for just ₹ 1 X
Cabgon 0.25 Tablet is a prescription medicine that is available as a Tablet. Acromegaly, Prolactinoma are some of its major therapeutic uses.
The correct dosage of Cabgon 0.25 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Cabgon 0.25 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Cabgon 0.25 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Cabgon 0.25 Tablet has a Mild effect for pregnant women and Severe effect on lactating mothers. Warnings related to Cabgon 0.25 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Cabgon 0.25 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Cabgon 0.25 Tablet in conditions like High Blood Pressure, Heart Disease, Depression. Other conditions have been mentioned below in the Cabgon 0.25 Tablet contraindications section.
Drug interactions for Cabgon 0.25 Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Cabgon 0.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Cabgon 0.25 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cabgon 0.25 Tablet safe for pregnant women?
Cabgon has little to no side effects in pregnant women.
Is the use of Cabgon 0.25 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Cabgon. So it is adviced to consult the doctor before using it.
What is the effect of Cabgon 0.25 Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Cabgon. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Cabgon 0.25 Tablet on the Liver?
The liver can be affected by Cabgon. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Cabgon only after medical advice.
What is the effect of Cabgon 0.25 Tablet on the Heart?
You may experience side effects on your heart after taking Cabgon. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Cabgon 0.25 Tablet unless your doctor advises you to do so -
Is this Cabgon 0.25 Tablet habit forming or addictive?
No, there is no any evidence that Cabgon 0.25 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cabgon 0.25 Tablet, you should not drive or work on any heavy machine, as Cabgon 0.25 Tablet can make you drowsy.
Is it safe?
Cabgon 0.25 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Cabgon 0.25 Tablet for mental disorders.
Interaction between Food and Cabgon 0.25 Tablet
There is no information on the effects of taking Cabgon 0.25 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Cabgon 0.25 Tablet
Drinking alcohol while taking Cabgon 0.25 Tablet may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)